EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate

Hafsia Abbas, Dalia Kheira Derkaoui, Louise Jeammet, Emilie Adicéam, Jérôme Tiollier, Hélène Sicard, Thorsten Braun, Jean-Luc Poyet iD

Biomolecules · 22.01.2024 · 14 (1) · 136

DOI: 10.3390/biom14010136 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 22.01.2024. Verfasst von Hafsia Abbas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Université Oran 1, Ahmed Ben Bella, Oran 31000, Algeria. Hauptthemen laut MEDLINE: Apoptosis Regulatory Proteins, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inserm.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apoptosis, or programmed cell death, is a fundamental process that maintains tissue homeostasis, eliminates damaged or infected cells, and plays a crucial role in various biological phenomena. The deregulation of apoptosis is involved in many human diseases, including cancer. One of the emerging players in the intricate regulatory network of apoptosis is apoptosis inhibitor 5 (API5), also called AAC-11 (anti-apoptosis clone 11) or FIF (fibroblast growth factor-2 interacting factor). While it may not have yet the same level of notoriety as some other cancer-associated proteins, API5 has garnered increasing attention in the cancer field in recent years, as elevated API5 levels are often associated with aggressive tumor behavior, resistance to therapy, and poor patient prognosis. This review aims to shed light on the multifaceted functions and regulatory mechanisms of API5 in cell fate decisions as well as its interest as therapeutic target in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apoptosis Regulatory ProteinsNeoplasmsHumansNuclear ProteinsApoptosisCell Differentiation

Stichwörter der Autor:innen

apoptosisapoptosis inhibitor 5cancertherapeutic target

Substanzen

Apoptosis Regulatory ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Université Oran 1, Ahmed Ben Bella, Oran 31000, Algeria.
  • Jalon Therapeutics, 75010 Paris, France.
  • Laboratoire de Transfert des Leucémies, EA3518, Institut de Recherche Saint Louis, Hôpital Saint Louis, Université de Paris, 75010 Paris, France.
  • AP-HP, Service d'Hématologie Clinique, Hôpital Avicenne, Université Paris XIII, 93000 Bobigny, France.
  • OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, 75010 Paris, France.
  • INSERM UMRS976, Institut de Recherche Saint Louis, Hôpital Saint Louis, 75010 Paris, France.

ORCID-Profile: Jean-Luc Poyet

Förderung

  • Inserm

Zitieren

APA

Abbas, H., Derkaoui, D. K., Jeammet, L., Adicéam, E., Tiollier, J., Sicard, H., Braun, T., & Poyet, J. L. (2024). Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate. Biomolecules, 14(1), 136. https://doi.org/10.3390/biom14010136

Vancouver

Abbas H, Derkaoui DK, Jeammet L, Adicéam E, Tiollier J, Sicard H, et al. Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate. Biomolecules. 2024;14(1):136. doi:10.3390/biom14010136

BibTeX
@article{Abbas2024,
  author = {Abbas, Hafsia and Derkaoui, Dalia Kheira and Jeammet, Louise and Adicéam, Emilie and Tiollier, Jérôme and Sicard, Hélène and Braun, Thorsten and Poyet, Jean-Luc},
  title = {Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {1},
  pages = {136},
  doi = {10.3390/biom14010136}
}
Kostenlos starten →